These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29054372)

  • 1. Simultaneously overcome tumor vascular endothelium and extracellular matrix barriers via a non-destructive size-controlled nanomedicine.
    Wang B; Zhai Y; Shi J; Zhuang L; Liu W; Zhang H; Zhang H; Zhang Z
    J Control Release; 2017 Dec; 268():225-236. PubMed ID: 29054372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
    J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-homing, pH- and ultrasound-responsive polypeptide-doxorubicin nanoconjugates overcome doxorubicin resistance in cancer therapy.
    Wang Z; He Q; Zhao W; Luo J; Gao W
    J Control Release; 2017 Oct; 264():66-75. PubMed ID: 28837822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Captopril improves tumor nanomedicine delivery by increasing tumor blood perfusion and enlarging endothelial gaps in tumor blood vessels.
    Zhang B; Jiang T; Tuo Y; Jin K; Luo Z; Shi W; Mei H; Hu Y; Pang Z; Jiang X
    Cancer Lett; 2017 Dec; 410():12-19. PubMed ID: 28939029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex.
    Han M; Lv Q; Tang XJ; Hu YL; Xu DH; Li FZ; Liang WQ; Gao JQ
    J Control Release; 2012 Oct; 163(2):136-44. PubMed ID: 22940126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro vascular toxicity assessment of NitDOX, a novel NO-releasing doxorubicin.
    Durante M; Frosini M; Fusi F; Gamberucci A; Chegaev K; Rolando B; Riganti C; Fruttero R; Saponara S
    Eur J Pharmacol; 2020 Aug; 880():173164. PubMed ID: 32437742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasmall gold nanosatellite-bearing transformable hybrid nanoparticles for deep tumor penetration.
    Son S; Deepagan VG; Shin S; Ko H; Min J; Um W; Jeon J; Kwon S; Lee ES; Suh M; Lee DS; Park JH
    Acta Biomater; 2018 Oct; 79():294-305. PubMed ID: 30134209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Damaging Tumor Vessels with an Ultrasound-Triggered NO Release Nanosystem to Enhance Drug Accumulation and T Cells Infiltration.
    Xu Y; Liu J; Liu Z; Chen G; Li X; Ren H
    Int J Nanomedicine; 2021; 16():2597-2613. PubMed ID: 33833514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity.
    Mazzucchelli S; Bellini M; Fiandra L; Truffi M; Rizzuto MA; Sorrentino L; Longhi E; Nebuloni M; Prosperi D; Corsi F
    Oncotarget; 2017 Jan; 8(5):8383-8396. PubMed ID: 28039473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
    Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T
    J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy.
    Mou Q; Ma Y; Zhu X; Yan D
    J Control Release; 2016 May; 230():34-44. PubMed ID: 27040815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin Nanoparticles Increase the Efficacy of Doxorubicin Hydrochloride Liposome Injection Based on Threshold Theory.
    Lin W; Li A; Qiu L; Huang H; Cui P; Wang J
    Mol Pharm; 2024 Jun; 21(6):2970-2980. PubMed ID: 38742943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.
    Han HS; Lee J; Kim HR; Chae SY; Kim M; Saravanakumar G; Yoon HY; You DG; Ko H; Kim K; Kwon IC; Park JC; Park JH
    J Control Release; 2013 Jun; 168(2):105-14. PubMed ID: 23474029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin-loaded nanocarriers: A comparative study of liposome and nanostructured lipid carrier as alternatives for cancer therapy.
    Fernandes RS; Silva JO; Monteiro LOF; Leite EA; Cassali GD; Rubello D; Cardoso VN; Ferreira LAM; Oliveira MC; de Barros ALB
    Biomed Pharmacother; 2016 Dec; 84():252-257. PubMed ID: 27664949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switchable PAMAM megamers for deep tumor penetration and enhanced cell uptake.
    Nekoueifard E; Radmanesh F; Zarkesh I; Ebrahimi M; Raoufi M; Abandansari HS; Baharvand H; Dinarvand R
    J Control Release; 2024 Nov; 375():478-494. PubMed ID: 39293528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release.
    Ruan S; Cao X; Cun X; Hu G; Zhou Y; Zhang Y; Lu L; He Q; Gao H
    Biomaterials; 2015 Aug; 60():100-10. PubMed ID: 25988725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU).
    Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR
    J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining the single-walled carbon nanotubes with low voltage electrical stimulation to improve accumulation of nanomedicines in tumor for effective cancer therapy.
    Lee PC; Peng CL; Shieh MJ
    J Control Release; 2016 Mar; 225():140-51. PubMed ID: 26812005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin-induced co-assembling nanomedicines with temperature-sensitive acidic polymer and their in-situ-forming hydrogels for intratumoral administration.
    Wan J; Geng S; Zhao H; Peng X; Zhou Q; Li H; He M; Zhao Y; Yang X; Xu H
    J Control Release; 2016 Aug; 235():328-336. PubMed ID: 27282415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.